• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

nanovibronix

NanoVibronix names new CEO

June 5, 2025 By Danielle Kirsh

NanoVibronix this week announced it appointed Doron Besser as CEO following the retirement of longtime leader Brian Murphy. The move comes shortly after the company’s acquisition of ENvue Medical, where Besser previously served as CEO. Murphy will remain on the board of directors to support leadership continuity. “Brian has been an integral part of NanoVibronix’s […]

Filed Under: Business/Financial News, Catheters Tagged With: nanovibronix, Personnel Moves

NanoVibronix announces reverse stock split

March 12, 2025 By Sean Whooley

NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock. The split comes at a ratio of one post-split share for every 11 pre-split shares. Tyler, Texas-based NanoVibronix expects the split to go into effect at 4:05 p.m. on March 13, 2025. It plans for its common stock […]

Filed Under: Business/Financial News, Catheters, Urology, Wall Street Beat Tagged With: nanovibronix, NanoVibronix Inc

NanoVibronix completes pilot study of UroShield

January 6, 2025 By Sean Whooley

NanoVibronix (Nasdaq:NAOV) announced today that it completed the first phase of a randomized controlled trial for its UroShield device. Researchers at the University of Michigan completed the first phase of the trial for UroShield, a portable ultrasonic therapeutic device. UroShield utilizes patented low-intensity surface acoustic wave (SAW) technology. This allows for the creation of low-frequency […]

Filed Under: Catheters, Clinical Trials, Urology Tagged With: nanovibronix, NanoVibronix Inc

NanoVibronix’s UroShield receives positive guidance from UK’s NICE

April 5, 2022 By Danielle Kirsh

NanoVibronix today received publication of guidance from National Institute for Health and Care Excellence (NICE) in the U.K. for its UroShield device. England’s Department of Health and Social Care’s NICE issued guidance suggesting that UroShield has the potential to provide significant patient and healthcare system benefits to prevent catheter-associated urinary tract infections. Further U.K.-based research […]

Filed Under: Catheters Tagged With: nanovibronix

NanoVibronix wins reimbursement from CMS for PainShield device

November 18, 2019 By Sean Whooley

NanoVibronix (NSDQ:NAOV) announced today that it won a unique reimbursement code from the Centers for Medicare and Medicaid for its PainShield surface acoustic wave portable ultrasonic therapeutic device. The Elmsford, N.Y.–based company develops medical devices based around its low-intensity SAW technology that allows the creation of low-frequency ultrasound waves that can be used in multiple medical […]

Filed Under: Business/Financial News, Medicare, Ultrasound Tagged With: nanovibronix, NanoVibronix Inc, Reimbursement

NanoVibronix touts trigeminal neuralgia PainShield study data

July 25, 2018 By Fink Densford

NanoVibronix (NSDQ:NAOV) yesterday released results from a study exploring the use of its PainShield device in treating patients with trigeminal neuralgia, touting improved pain relief and quality of life. The PainShield is a device designed to treat pain in nerves, muscles and joints through the delivery of localized ultrasound, the Elmsford, N.Y.-based company said. In the […]

Filed Under: Clinical Trials, Pain Management, Ultrasound Tagged With: nanovibronix

7 medtech stories we missed this week: April 6, 2018

April 6, 2018 By Danielle Kirsh

From CHF Solutions’s distribution deal to Guided Therapeutics’s licensing agreement, here are seven medtech stories we missed this week but throught were still worth mentioning. 1. CHF inks Spanish distribution deal CHF Solutions announced in an April 5 press release that it has signed a distribution agreement with Dimedix Surgical. The distribution agreement will allow […]

Filed Under: Catheters, Diagnostics, Food & Drug Administration (FDA), Hospital Care, Imaging, Implants, Regulatory/Compliance, Surgical, Ultrasound, Urology Tagged With: Asahi Intecc, aziyobiologics, Biotronik, CHF Solutions Inc., dimedixsurgical, Guided Therapeutics Inc., hypermed, Instrumed, Johnson and Johnson, nanovibronix

5 medtech stories we missed this week: Dec. 29, 2017

December 29, 2017 By Danielle Kirsh

From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Regulatory/Compliance Tagged With: Guided Therapeutics Inc., Impulse Dynamics, K2M, MedTech, Muscle Activation Technique, nanovibronix, neuxtechnologies

5 medtech stories we missed this week: Dec. 22, 2017

December 22, 2017 By Danielle Kirsh

From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its […]

Filed Under: 510(k), Diagnostics, Food & Drug Administration (FDA), Hospital Care, Imaging, Implants, Pain Management, Regulatory/Compliance Tagged With: camberspine, Hepa Wash, In2Bones, MedTech, nanovibronix, Stimwave

NanoVibronix inks UK UroShield distro deal with IMS Ultrasound

December 14, 2017 By Fink Densford

NanoVibronix (NSDQ:NAOV) said today it inked a deal with the U.K.’s IMS Ultrasound to make it the exclusive U.K. distributor of its UroShield device, designed to prevent catheter-acquired urinary tract infections. The UroShield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also preventing bacterial colonization […]

Filed Under: Business/Financial News, Distribution, Ultrasound Tagged With: nanovibronix

NanoVibronix touts lowered UTIs in interim UroShield study results

November 8, 2017 By Fink Densford

NanoVibronix (NSDQ:NAOV) today released interim results from a trial of its UroShield ultrasound device designed to prevent bacteria and biofilms from forming on urinary catheters, touting a low rate of catheter-acquired urinary tract infections. The Uroshield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also […]

Filed Under: Catheters, Clinical Trials, Urology Tagged With: nanovibronix

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy